Skip to content
Screener

Xencor XNCR Other Non-Current Assets

Other Non-Current Assets at other companies

Amgen logo
AmgenAMGN
$12.98B+17.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$2.31B
Janux Therapeutics logo
Janux TherapeuticsJANX
$2.91M+8.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$62.1M+8.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$256K0.0%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$20.42K0.0%

Other financials

Income statement

See full
Revenue$51.2M+17.5%
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.55B+210%
Enterprise value$1.67B+150%
P/S14.7×+11.3×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemJune 30,2026December 31,2025
Property and equipment, net50,01353,308
Right-of-use assets35,98637,592
Patents, licenses, and other intangible assets, net6,5248,385
Other assets498498
Total assets$724,960$875,495
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$12,648$10,828

Item 1. Financial Statements

FAQ

What is Xencor's other non-current assets?
Xencor (XNCR) reported other non-current assets of $498K in Q2 2026.
How has Xencor's other non-current assets changed year-over-year?
Xencor's other non-current assets decreased by 0.0% year-over-year, from $498K to $498K.
What is the long-term trend for Xencor's other non-current assets?
Over 5 years (2020 to 2025), Xencor's other non-current assets has grown at a -46.0% compound annual growth rate (CAGR), from $10.81M to $498K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Xencor's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude